Nikolaos S.
- Country
- Greece
- Department
- 1st Department of Neurology
Research Overview
- Oral semaglutide versus placebo in early Alzheimer’s disease: a randomized double-blind trial in patients with mild cognitive impairment or mild dementia
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of AVP‑786 (deudextromethorphan hydrobromide/quinidine) for Agitation in Alzheimer’s Dementia
- Evaluation of Oral Semaglutide Efficacy and Safety in Patients with Early Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 124 of 196 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in studying therapeutic approaches for Alzheimer's disease, with particular focus on early-stage interventions and cognitive decline management.
- Early Alzheimer's Disease Treatment
- Mild Cognitive Impairment (MCI)
- Mild Dementia Management
Their research encompasses cognitive function assessment and therapeutic interventions in early-stage neurodegeneration.
Behavioral Symptoms
The investigator focuses on addressing behavioral manifestations in Alzheimer's patients, particularly targeting agitation symptoms and their management.
- Agitation Treatment
- Behavioral Interventions
- Symptom Management
Their work involves evaluating novel therapeutic approaches for behavioral symptoms in dementia patients.
Clinical Assessment
The investigator utilizes specialized assessment tools including the Clinical Dementia Rating Scale to evaluate cognitive and functional outcomes in neurodegenerative conditions.
- Cognitive Function Assessment
- Therapeutic Efficacy Evaluation
- Standard of Care Enhancement
Their expertise includes comprehensive evaluation of treatment outcomes in dementia care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.